Laddar...
Protection against Respiratory Syncytial Virus by Inactivated Influenza Virus Carrying a Fusion Protein Neutralizing Epitope in a chimeric hemagglutinin
A desirable vaccine against respiratory syncytial virus (RSV) should induce neutralizing antibodies without eliciting abnormal T cell responses to avoid vaccine-enhanced pathology. In an approach to deliver RSV neutralizing epitopes without RSV-specific T cell antigens, we genetically engineered chi...
Sparad:
| I publikationen: | Nanomedicine |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4811744/ https://ncbi.nlm.nih.gov/pubmed/26656630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2015.11.007 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|